Since the identification of the hereditary breast and ovarian cancer genes BRCA1 and BRCA2 (BRCA1/2) in 1994–5 [1, 2], the concept of hereditary cancer syndromes has been widely accepted by the medical community. Here, BRCA1 is linked to Inherited cancer-predisposing syndrome.